Bruce Booth

Bruce Booth has an estimated net worth of $546 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., MIRAGEN THERAPEUTICS, INC., Unum Therapeutics Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., ZAFGEN, INC., AVROBIO, Inc., and Sionna Therapeutics, Inc..

2018 was Bruce Booth's most active year for acquiring shares with 13 total transactions. Bruce Booth's most active month to acquire stocks was the month of May. 2025 was Bruce Booth's most active year for disposing of shares, totalling 79 transactions. Bruce Booth's most active month to dispose stocks was the month of September. 2019 saw Bruce Booth paying a total of $15,072,875.45 for 911,617 shares, this is the most they've acquired in one year. In 2021 Bruce Booth cashed out on 471,483 shares for a total of $27,728,388.00, their largest year based on trade value.